In This Article:
The UK market has recently faced headwinds, with the FTSE 100 closing lower due to weak trade data from China and broader global economic concerns. Despite these challenges, there are opportunities in the small-cap sector where undervalued stocks with insider action can offer potential for growth.
Top 10 Undervalued Small Caps With Insider Buying In The United Kingdom
| Name | PE | PS | Discount to Fair Value | Value Rating |
|---|---|---|---|---|
| Bytes Technology Group | 24.8x | 5.6x | 11.88% | ★★★★★☆ |
| C&C Group | NA | 0.4x | 47.51% | ★★★★★☆ |
| GB Group | NA | 3.0x | 33.73% | ★★★★★☆ |
| Norcros | 7.7x | 0.5x | 1.35% | ★★★★☆☆ |
| Foxtons Group | 26.7x | 1.3x | 45.25% | ★★★★☆☆ |
| Harworth Group | 13.9x | 7.3x | -501.48% | ★★★★☆☆ |
| CVS Group | 22.5x | 1.2x | 40.83% | ★★★★☆☆ |
| Hochschild Mining | NA | 1.6x | 45.90% | ★★★★☆☆ |
| Diaceutics | NA | 4.4x | -1.81% | ★★★☆☆☆ |
| Hammerson | NA | 5.9x | 17.76% | ★★★☆☆☆ |
Let's uncover some gems from our specialized screener.
Assura
Simply Wall St Value Rating: ★★★☆☆☆
Overview: Assura is a UK-based real estate investment trust focused on designing, building, and managing primary care medical centers with a market cap of approximately £2.24 billion.
Operations: Assura's revenue primarily comes from its core segment, generating £157.8 million. The company reported a gross profit of £143.3 million for the latest period ending on 2024-03-31, with operating expenses totaling £14 million and non-operating expenses at £158.1 million. Notably, the net income margin has shown significant variability recently, reaching -0.18% in the same period.
PE: -43.7x
Assura, a healthcare property investor and developer, is currently trading at attractive valuations. The company has forecasted earnings growth of 40.91% per year and announced a strategic GBP 250 million joint venture with the Universities Superannuation Scheme to invest in NHS infrastructure. Insider confidence is evidenced by recent share purchases over the past six months. Despite reporting a net loss of GBP 28.8 million for FY2024, Assura's strategic moves and strong pipeline suggest potential for future growth in the UK healthcare sector.
-
Take a closer look at Assura's potential here in our valuation report.
-
Examine Assura's past performance report to understand how it has performed in the past.
International Personal Finance
Simply Wall St Value Rating: ★★★★★★
Overview: International Personal Finance provides consumer credit services through its digital platform and home credit operations in Mexico and Europe, with a market cap of approximately £0.22 billion.
Operations: International Personal Finance generates revenue from three primary segments: Digital (£128.1M), Mexico Home Credit (£276.1M), and European Home Credit (£355.3M). The company's gross profit margin has shown a range between 62.47% and 89.76% over the observed periods, with recent figures around 80%. Operating expenses are consistently significant, often exceeding £400 million, impacting net income margins which have varied from -9.71% to 8.79%.